[Antiagregants, anticoagulants and proximal femur fracture].

Abstract

Hip fractures are common in the elderly, particularly due to an increased susceptibility to falls and greater bone frailty, especially in women. The consequences of such events are potentially serious. Early management (< 48 hours) significantly reduces the mortality and postoperative complications. Because of their comorbidities, older people are often on antiplatelet therapy, anticoagulant therapy, or both. However, there are no definitive recommendations for the perioperative management of antiplatelet and anticoagulant treatment in the early surgery of hip fractures. The purpose of this article is to review the management of these patients.

• Authors: Alexandra Malliou, Kevin Moerenhout, Daniel Wagner, Marc Humbert
• Journal: Revue medicale suisse (Rev Med Suisse) Vol. 19 Issue 848 Pg. 2055-2059 (Nov 01 2023) ISSN: 1660-9379 [Print] Switzerland
• Vernacular Title: Antiagrégants, anticoagulants oraux directs et fracture du fémur proximal.
• PMID: 37910055 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Anticoagulants

Topics

• Aged
• Humans
• Anticoagulants
• Frailty
• Hip Fractures (prevention & control, surgery)
• Postoperative Complications (prevention & control)
• Proximal Femoral Fractures